welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
study id #: NCT00026468
condition: Colorectal Cancer, Small Intestine Cancer
status: withdrawn
purpose:RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
intervention: Drug: exisulind
expertly curated content related to this topic
- Non Steroidal Anti-Inflammatory Drugs (NSAID) and Aspirin for Preventing Colorectal Adenomas and CarcinomasBACKGROUND : There is evidence from expe...
- Familial Investigations of Childhood Cancer PredispositionWhile it is well recognized that heredit...
- Colorectal Cancer in Primary Care: Recognizing and Reducing RiskA vast amount of information exists rega...
- Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposisIn a randomized clinical chemoprevention...
- Total Proctocolectomy with Brooke Ileostomyhttp://rlv.zcache.ca/total_proctocolecto...
- Coxib-inhibition of Duodenal Polyp Growth in FAPPreliminary data indicate a protective e...
- Chemoprevention in Lynch SyndromeCAPP1 tested aspirin 600 mg/day and/or r...